These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 10346705)

  • 1. The Lohr decision: FDA perspective and position.
    Porter MJ
    Food Drug Law J; 1997; 52(1):7-11. PubMed ID: 10346705
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical devices; preemption of state product liability claims--FDA. Correction.
    Fed Regist; 1997 Dec; 62(242):66179. PubMed ID: 10179302
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical devices; preemption of state product liability claims--FDA. Proposed rule.
    Fed Regist; 1997 Dec; 62(239):65384-8. PubMed ID: 10176832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
    Fed Regist; 1998 Jul; 63(142):39789-90. PubMed ID: 10181516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr.
    Jarcho DG
    Food Drug Law J; 1996; 51(4):613-8. PubMed ID: 11797730
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical device preemption after Medtronic, Inc. v. Lohr.
    Neraas MB
    Food Drug Law J; 1996; 51(4):619-29. PubMed ID: 11797731
    [No Abstract]   [Full Text] [Related]  

  • 7. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability.
    Green W
    Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA: the regulatory process.
    Slutsky AS
    Respir Care; 1995 Sep; 40(9):952-6. PubMed ID: 10152239
    [No Abstract]   [Full Text] [Related]  

  • 9. Perspectives. Battle heats up over product liability reform.
    Miller D
    Faulkner Grays Med Health; 1995 Apr; 49(17):suppl 1-4. PubMed ID: 10141116
    [No Abstract]   [Full Text] [Related]  

  • 10. Injured consumers and the FDA. Should federal preemption protect medical device manufacturers under a quasi-governmental immunity?
    Truitt BI
    J Leg Med; 1994 Mar; 15(1):155-84. PubMed ID: 8201276
    [No Abstract]   [Full Text] [Related]  

  • 11. The Safe Medical Devices Act.
    Williams MA
    South Hosp; 1992; 58(2):16-7. PubMed ID: 10118188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal overprotection.
    Friedman JH
    Med Health R I; 2004 Oct; 87(10):294. PubMed ID: 15559378
    [No Abstract]   [Full Text] [Related]  

  • 13. Who should protect the public? The Supreme Court and medical device regulation.
    Korobkin R
    N Engl J Med; 2007 Oct; 357(17):1680-1. PubMed ID: 17960010
    [No Abstract]   [Full Text] [Related]  

  • 14. Civil and criminal liability associated with food recalls.
    Packman JM
    Food Drug Law J; 1998; 53(3):437-52. PubMed ID: 10346721
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical industry wins "round one" in protections against product liability claims.
    Gatty B
    Hosp Formul; 1995 Apr; 30(4):238, 237. PubMed ID: 10141868
    [No Abstract]   [Full Text] [Related]  

  • 16. The FDA defense: a prescription for easing the pain of punitive damage awards in medical products liability cases.
    Marthaler AL
    Spec Law Dig Health Care Law; 1997 Sep; (223):9-45. PubMed ID: 10173273
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical device recalls from 2004 to 2006: a focus on Class I recalls.
    Villarraga ML; Guerin HL; Lam T
    Food Drug Law J; 2007; 62(3):581-92. PubMed ID: 17915400
    [No Abstract]   [Full Text] [Related]  

  • 18. Tort law deference to FDA regulation of medical devices.
    Green MD; Schultz WB
    Georgetown Law J; 2000 Jul; 88(7):2119-45. PubMed ID: 11503660
    [No Abstract]   [Full Text] [Related]  

  • 19. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products.
    Struve CT
    Cornell Law Rev; 2008 Jul; 93(5):1039-74. PubMed ID: 18618970
    [No Abstract]   [Full Text] [Related]  

  • 20. Postmarket surveillance for medical devices: America's new strategy.
    Normand SL; Hatfield L; Drozda J; Resnic FS
    BMJ; 2012 Oct; 345():e6848. PubMed ID: 23060660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.